GlassScriptPhysician profile
Haibi Cai
NPI 1508211780
$832.45
in general payments reported to CMS, 2019-2025
5 companies · $52.92 in 2025
The $52.92 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13.00 · 2024: $767 · 2025: $52.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577 · Travel and Lodging: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.39 |
| Travel and Lodging | $255.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $495.30 | 2024 | Zilretta |
| Biogen, INC. | $149.30 | 2024 | Spinraza |
| Revance Therapeutics, INC. | $121.93 | 2024 | Daxxify |
| Ipsen Biopharmaceuticals, INC | $52.92 | 2025 | Dysport |
| Merz Pharmaceuticals, LLC | $13.00 | 2023 | Xeomin |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haibi Cai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.